AFP and hepatocellular carcinoma: Additionally, serum levels of miR-21 were assessed with a positive rate of 77.6% (45/58) in AFP-negative HCC group, and were with a positive rate of 82.9% (102/123, Figure 5B) in AFP-positive HCC group.